During the past decade, UMC Utrecht; Polkliniek Neuromusculaire ziekten conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UMC Utrecht; Polkliniek Neuromusculaire ziekten" are "Muscular Atrophy, Spinal" (2 trials) and "Spinal Muscular Atrophy" (1 trials). Many other conditions were trialed in "UMC Utrecht; Polkliniek Neuromusculaire ziekten" in a lesser frequency.

Most popular intervention types in "UMC Utrecht; Polkliniek Neuromusculaire ziekten" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Olesoxime" (1 trials), "RO6885247" (1 trials), "Risdiplam" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "UMC Utrecht; Polkliniek Neuromusculaire ziekten" are 3 trials for "All" genders.

Currently, there are NaN active trials in "UMC Utrecht; Polkliniek Neuromusculaire ziekten". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UMC Utrecht; Polkliniek Neuromusculaire ziekten, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UMC Utrecht; Polkliniek Neuromusculaire ziekten, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".